<?xml version="1.0" encoding="UTF-8"?>
<p>In France, the prevalence of anti-HEV antibodies in blood banks was 3.2%, which is similar to that of other industrialized countries. However, the HEV IgG prevalence among blood donors from Midi-Pyrénées, a province in southern France, is 52.5%, the maximum rate described in developed countries, implying that HEV is hyperendemic to Midi-Pyrénées [
 <xref rid="B67-medicina-56-00206" ref-type="bibr">67</xref>]. Seroprevalence rates among Dutch blood donors is 20.6%; these high rates of HEV are perplexing investigators as Denmark is not located near an endemic region nor does it have explained risk factors responsible for the illness [
 <xref rid="B68-medicina-56-00206" ref-type="bibr">68</xref>]. However, rates are considerably lower in Switzerland at 4.9%. The low seroprevalence may be due to differences in sensitivity of assay method used and the stringent laws regulating animal and meat imports in the country [
 <xref rid="B69-medicina-56-00206" ref-type="bibr">69</xref>].
</p>
